Literature DB >> 30901718

Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality.

Wenzheng Guo1, Min Hu2, Jingjing Wu3, Aiping Zhou4, Yueling Liao5, Hongyong Song6, Dongliang Xu7, Yanbin Kuang8, Tong Wang9, Bo Jing10, Kaimi Li11, Jing Ling12, Donghua Wen13, Wenjuan Wu14.   

Abstract

AIMS: Lung cancer remains the leading cause of cancer incidence and mortality. Although cigarette smoke is regarded as a high risk factor for lung tumor initiation, the role of the lung tumor suppressor GPRC5A in smoking-induced lung cancer is unclear. MAIN
METHODS: We obtained two lung cancer cohorts from the TCGA and GEO databases. Bioinformatics analysis showed differential gene expression in the cohorts. Quantitative real-time PCR, Western Blot and Gprc5a-/- mice uncovered the relationship between cigarette smoke and lung cancer in the GPRC5A deletion system in vitro and in vivo. KEY
FINDINGS: Bioinformatics analysis showed that the smoking lung cancer patients with low expression of GPRC5A had poor overall survival compared to the patients with high GPRC5A expression. Further analysis revealed that cancer-related stemness pathways such as the Hippo signaling pathway were induced in smoking patients with low GPRC5A expression. Additionally, we detected enriched expression of WNT5A and DLX5 in normal human lung epithelial 16HBE cells and human lung cancer H1299 cells in vitro. A relationship between cigarette smoke extract (NNK) and lung tumor initiation was observed in Gprc5a-/- mice. SIGNIFICANCE: The lung tumor suppressor gene GPRC5A played a protective role in cigarette smoke-induced lung tumor initiation, providing a target for the prevention of lung cancer development and monitoring of prognosis.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  GPRC5A; Lung cancer; Smoke; Stemness

Mesh:

Substances:

Year:  2019        PMID: 30901718     DOI: 10.1016/j.biopha.2019.108791

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Lung proteomic biomarkers associated with chronic obstructive pulmonary disease.

Authors:  Yu-Hang Zhang; Michael R Hoopmann; Peter J Castaldi; Kirsten A Simonsen; Mukul K Midha; Michael H Cho; Gerard J Criner; Raphael Bueno; Jiangyuan Liu; Robert L Moritz; Edwin K Silverman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-20       Impact factor: 5.464

2.  Identification of SRXN1 and KRT6A as Key Genes in Smoking-Related Non-Small-Cell Lung Cancer Through Bioinformatics and Functional Analyses.

Authors:  Jiazhen Zhou; Guanqing Jiang; Enwu Xu; Jiaxin Zhou; Lili Liu; Qiaoyuan Yang
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

3.  PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model.

Authors:  Tong Wang; Bo Jing; Dongliang Xu; Yueling Liao; Hongyong Song; Beibei Sun; Wenzheng Guo; Jianhua Xu; Kaimi Li; Min Hu; Shuli Liu; Jing Ling; Yanbin Kuang; Tuo Zhang; Siwei Zhang; Feng Yao; Binhua P Zhou; Jiong Deng
Journal:  Oncogene       Date:  2020-02-14       Impact factor: 9.867

Review 4.  [Advances of Exosomes Extraction and Its Mechanism in Early Diagnosis of Lung Cancer].

Authors:  Dan Luo; Chunlei Li; Lun Wu; Qinhua Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-08-05

5.  Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode.

Authors:  Zhou Jiawei; Mu Min; Xing Yingru; Zhang Xin; Li Danting; Liu Yafeng; Xie Jun; Hu Wangfa; Zhang Lijun; Wu Jing; Hu Dong
Journal:  Front Mol Biosci       Date:  2020-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.